These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30075812)

  • 1. Survey on knowledge of non-alcoholic fatty liver disease (NAFLD) among doctors in Sri Lanka: a multicenter study.
    Matthias AT; Fernandopulle ANR; Seneviratne SL
    BMC Res Notes; 2018 Aug; 11(1):556. PubMed ID: 30075812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary care practitioners survey of non-alcoholic fatty liver disease.
    Said A; Gagovic V; Malecki K; Givens ML; Nieto FJ
    Ann Hepatol; 2013; 12(5):758-65. PubMed ID: 24018493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and associations of non-alcoholic fatty liver disease (NAFLD) in Sri Lankan patients with type 2 diabetes: A single center study.
    Herath HMM; Kodikara I; Weerarathna TP; Liyanage G
    Diabetes Metab Syndr; 2019; 13(1):246-250. PubMed ID: 30641706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-life Perception and Practice Patterns of NAFLD/NASH in Romania: Results of a Survey Completed by 102 Board-certified Gastroenterologists.
    Iacob S; Ester C; Lita M; Ratziu V; Gheorghe L
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):183-9. PubMed ID: 27308649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis.
    Patel PJ; Banh X; Horsfall LU; Hayward KL; Hossain F; Johnson T; Stuart KA; Brown NN; Saad N; Clouston A; Irvine KM; Russell AW; Valery PC; Williams S; Powell EE
    Intern Med J; 2018 Feb; 48(2):144-151. PubMed ID: 29083080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional pilot study to assess primary healthcare workers' knowledge of nonalcoholic fatty liver disease in a marginalized community in Mexico.
    Vidal-Cevallos P; Ordóñez-Vázquez AL; Procopio-Mosso O; Cardoso-Arias R; Uribe M; Chávez-Tapia NC
    Sci Rep; 2021 Jun; 11(1):12100. PubMed ID: 34103552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
    Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG
    Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus.
    Kasturiratne A; Weerasinghe S; Dassanayake AS; Rajindrajith S; de Silva AP; Kato N; Wickremasinghe AR; de Silva HJ
    J Gastroenterol Hepatol; 2013 Jan; 28(1):142-7. PubMed ID: 22989165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?
    Blond E; Disse E; Cuerq C; Drai J; Valette PJ; Laville M; Thivolet C; Simon C; Caussy C
    Diabetologia; 2017 Jul; 60(7):1218-1222. PubMed ID: 28352941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation and analysis of the knowledge of nonalcoholic fatty liver disease among residents in Hebei Province, China].
    Liang QF; Wang YD; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):760-765. PubMed ID: 29108205
    [No Abstract]   [Full Text] [Related]  

  • 11. Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Otgonsuren M; Estep MJ; Hossain N; Younossi E; Frost S; Henry L; Hunt S; Fang Y; Goodman Z; Younossi ZM
    J Gastroenterol Hepatol; 2014 Dec; 29(12):2006-13. PubMed ID: 25039333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka.
    Perera N; Indrakumar J; Abeysinghe WV; Fernando V; Samaraweera WM; Lawrence JS
    BMC Cardiovasc Disord; 2016 Feb; 16():37. PubMed ID: 26869052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease and its associations among adolescents in an urban, Sri Lankan community.
    Rajindrajith S; Pathmeswaran A; Jayasinghe C; Kottahachchi D; Kasturiratne A; de Silva ST; Niriella MA; Dassanayake AS; de Silva AP; de Silva HJ
    BMC Gastroenterol; 2017 Nov; 17(1):135. PubMed ID: 29187144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of knowledge and awareness between consultant physicians and resident doctors about non-alcoholic fatty liver disease.
    Lavekar AS; Deshpande A; Raje D
    Clin Exp Hepatol; 2020 Dec; 6(4):374-383. PubMed ID: 33511287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NON-ALCOHOLIC FATTY LIVER DISEASE].
    Bukmir L; Smokrović H; Diminić-Lisica I; Ljubotina A; Popović B
    Acta Med Croatica; 2015 Nov; 69(4):305-10. PubMed ID: 29083841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
    Pallayova M; Taheri S
    Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?
    Byrne CD; Targher G
    Diabetologia; 2016 Jun; 59(6):1141-4. PubMed ID: 27053232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease: a survey of involvement of primary care physicians.
    Mari A; Omari S; Abu Baker F; Abu Much S; Said Ahmad H; Khoury T; Nseir W; Mahamid M
    Minerva Gastroenterol Dietol; 2019 Dec; 65(4):255-258. PubMed ID: 31646850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.
    Aller R; Fernández-Rodríguez C; Lo Iacono O; Bañares R; Abad J; Carrión JA; García-Monzón C; Caballería J; Berenguer M; Rodríguez-Perálvarez M; Miranda JL; Vilar-Gómez E; Crespo J; García-Cortés M; Reig M; Navarro JM; Gallego R; Genescà J; Arias-Loste MT; Pareja MJ; Albillos A; Muntané J; Jorquera F; Solà E; Hernández-Guerra M; Rojo MÁ; Salmerón J; Caballería L; Diago M; Molina E; Bataller R; Romero-Gómez M
    Gastroenterol Hepatol; 2018 May; 41(5):328-349. PubMed ID: 29631866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
    Zhu C; Zhou D; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):81-4. PubMed ID: 26983471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.